Nyheter

Toutatis AB opens a K.O.S-clinic in Gothenburg within the franchise agreement with Chordate

13 november, 2018

Kista, November 13, 2018. Toutatis AB (“Toutatis”) extends operations in its franchise agreement with Chordate Medical AB (“Chordate”), the subsidiary of Chordate Medical Holding AB (publ). On the fourth of December, Toutatis opens a K.O.S-clinic in Gothenburg, which offers private-paying patients Chordate’s treatment for non-allergic rhinitis (“nasal congestion”).

“As we have previously communicated, we will continue to process the Swedish market with our B2C model. It is gratifying that, within the framework of our franchise agreement, we can note that Toutatis is expanding its operations with a clinic in Gothenburg, which is already receiving bookings for the start of December 4th. We will continue to increase our presence in Sweden by adding additional franchise clinics to our B2C concept” says Anders Weilandt, CEO of Chordate.

For more information, please contact:
Anders Weilandt, CEO
anders.weilandt@chordate.com
Phone: +46 (0) 733 87 42 77

Information:
The information was provided, through the contact of the above contact person,
for publication on November 13, 2018 at. 08:30 CET.

Fler Nyheter

Pressmeddelanden

Vill du läsa våra pressmeddelanden finns de under Investor relations eller via länken nedan.

Pressmeddelanden

För frågor om Chordates aktiekurs eller andra investeringsrelaterade ämnen, vänligen se om svaret finns här.

För frågor om K.O.S-behandlingens medicinska effekter, vänligen se om svaret finns här.

För att komma i kontakt med Chordate gällande andra frågor, använd formuläret här bredvid. Vi gör vårt bästa för att svara så snabbt som möjligt.

Kontakta oss


Informationen hanteras enligt vår integritetspolicy.